63 research outputs found
Promoting opioids, a story about how to influence medical science and opinions
Key origins of the opioid crisis in the US lie in some pharmaceutical companiesâ substantial efforts to sell prescription painkillers. To legitimize opioids, the companies built up a body of medical science and opinions, and channels with which to communicate. Archival searches found 876 contracts that together provide information on how Mallinckrodt, an opioid manufacturer, attempted the ghost-management of medicine. These recordsâavailable because of litigationâinvolved contract research organizations, medical education and communication companies, publishers, professional societies, researchers, and other people who could be Mallinckrodtâs agents. Together, they produced and circulated scientific messages to increase physiciansâ comfort with prescribing opioids. This article gives an overview of that activity, as seen in the contracts and related documents
Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
Sismondo discusses how pharmaceutical companies and their agents shape multiple steps in the research, analysis, writing, and publication of articles
Clogging the machinery: the BBC's experiment in science coordination, 1949â1953
In 1949, physicist Mark Oliphant criticised the BBCâs handling of science in a letter to the Director General William Haley. It initiated a chain of events which led to the experimental appointment of a science adviser, Henry Dale, to improve the âcoordinationâ of science broadcasts. The experiment failed, but the episode revealed conflicting views of the BBCâs responsibility towards science held by scientists and BBC staff. For the scientists, science had a special status, both as knowledge and as an activity, which in their view obligated the BBC to make special arrangements for it. BBC staff, however, had their own professional procedures which they were unwilling to abandon. The events unfolded within a few years of the end of the Second World War, when social attitudes to science had been coloured by the recent conflict, and when the BBC itself was under scrutiny from the William Beveridgeâs Committee. The BBC was also embarking on new initiatives, notably the revival of adult education. These contextual factors bear on the story, which is about the relationship between a public service broadcaster and the external constituencies it relies on, but must appear to remain independent from. The article therefore extends earlier studies showing how external bodies have attempted to manipulate the inner workings of the BBC to their own advantage (e.g. those by Doctor and Karpf) by looking at the little-researched area of science broadcasting. The article is largely based on unpublished archive documents
EnvoĂ»tement : fabrique et management des leaders dâopinion
La quintessence du leader dâopinionLe Dr Kessel, sourire aux lĂšvres, tirĂ© Ă quatre Ă©pingles, mĂ©decin et professeur, la cinquantaine, monte sur lâestrade. Il porte un costume qui doit ĂȘtre en crĂȘpe de coton, une chemise Ă rayures bleues et blanches et une cravate jaune, une tenue parfaitement adaptĂ©e aux grandes chaleurs en cette journĂ©e dâĂ©tĂ© Ă Philadelphie. Le Dr Kessel, qui a Ă©tĂ© prĂ©sentĂ© comme lâauteur de plus de 500 publications et « lâune des stars des neurosciences les plus brillantes ..
Lâextraction des donnĂ©es en marge de la santĂ©
Entre 2009 et 2013, lâAgence europĂ©enne des mĂ©dicaments (AEM) a homologuĂ© quarante-huit mĂ©dicaments anticancĂ©reux. Une Ă©tude rĂ©vĂšle quâau moment de cette homologation, il nây avait aucune preuve dâune amĂ©lioration de la qualitĂ© de vie ou dâune augmentation des chances de survie dans 65 % des usages pour lesquels ces mĂ©dicaments avaient Ă©tĂ© approuvĂ©s. Il semble que lâAEM ait fondĂ© ses homologations sur des espoirs et non sur des preuves. Il sâavĂšre que ces espoirs nâĂ©taient justifiĂ©s que dans..
Ghost-Managed Medicine
Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this âassemblage marketingâ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed â or âpolitical economies of knowledgeâ â and not just about truth and falsity of medical knowledge. In pharmaceutical companiesâ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companiesâ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctorsâ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharmaâs many invisible hands are busy throughout medicine, and medicine changes as a result
Remerciements
Je suis ravi quâENS Ăditions ait dĂ©cidĂ© de publier ce volume. Je remercie lâĂ©quipe dâENS Ăditions dâavoir pris lâinitiative de cette publication, Laurent Dartigues dâavoir acceptĂ© le travail de direction scientifique pour ce projet et de lâavoir menĂ© Ă bien, ainsi que pour sa rĂ©vision mĂ©ticuleuse de la traduction effectuĂ©e avec Jean-Claude Zancarini, co-directeur de la collection Gouvernement en question(s) Ă ENS Ăditions, Samantha SaĂŻdi pour sa traduction gĂ©nĂ©reuse, Mathias Girel, auteur de..
Amoindrir et contraindre la capacitĂ© dâagir
Changer les habitudesBien que les mĂ©decins gĂ©nĂ©ralistes parviennent Ă se leurrer sur la finalitĂ© du dĂ©marchage â, et il est Ă©tonnant quâils y arrivent aussi souvent â les visiteurs mĂ©dicaux qui se rendent dans leur cabinet sont trĂšs clairement des vendeurs. Les tactiques de ces derniers peuvent prendre des formes trĂšs variĂ©es, et certaines ne ressemblent pas vraiment Ă de la vente forcĂ©e, comme la « description dĂ©taillĂ©e » qu'ils font des mĂ©dicaments de leur portefeuille et qui offre, notamm..
- âŠ